CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 151 enrolled
Drug / intervention
Ciprofloxacin Tabletsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05916105
NCT05916105N/ACompleted

Drug Utilization Evaluation Study of Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting: A Cross-Sectional Study

Damanhour University·observational·Posted Jun 23, 2023·Updated Jun 23, 2023

In Brief

An observational study evaluating Ciprofloxacin Tablets for Ciprofloxacin Adverse Reaction. Completed, enrolled 151 participants across 1 site.

Detailed Summary

Background: Ciprofloxacin is a fluoroquinolone that is commonly used to treat a variety of diseases. Ciprofloxacin resistance is rising, resulting in suboptimal patient care. The goal of this study was to evaluate ciprofloxacin use in the community in terms of acceptable prescription, dose, frequency, and duration of use. Methods: A cross-sectional research was done in Egyptian community pharmacies by community pharmacists. Patients who were administered oral ciprofloxacin during the research period were included.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJun 23, 2023
Enrollment StartSep 1, 2021
Primary CompletionFeb 28, 2022
Study CompletionMar 1, 2022
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 3.0 years ago

Interventions

Ciprofloxacin Tabletsdrug

Ciprofloxacin antibiotic